• 1
    Rizzetto M, Ciancio A. Chronic HBV-related liver disease. Mol Aspects Med 2008; 29: 7284.
  • 2
    Shan J. China has 120m hepatitis B carriers. China Daily, September 1, 2007.
  • 3
    McNeil DG Jr. Blood pressure is most lethal in poor and middle-income countries. The New York Times, May 6, 2008.
  • 4
    Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359: 14861500.
  • 5
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 6
    Zou YH, Yang Y, Wu Q. The effect of Huang Qi extract on anti-hepatitis B virus in vitro [in Chinese]. Journal of Anhui Medical University 2003; 38: 267269.
  • 7
    Huang ZM, Yang XB, Gao WB, Shao XW, Chen HS. Inhibition of extracts of five Chinese traditional medicines on DHBV-RT-DNAP in vitro [in Chinese]. Special Journal Pharmacy of People's Mil Surg 1997; 13: 7173.
  • 8
    Wu XM, Yuan WS. In vitro study of the anti-HBV activity of astragalus [in Chinese]. Guangdong Medical Journal 2008; 29: 3738.
  • 9
    Zhang FX, Sun DX, Li MX. Study on the preparation of astragals polysaccharides and the treatment in hepatitis [in Chinese]. Journal of Pharmicol and Biologic Technology 1995; 2: 2628.
  • 10
    Tang Y, Zou HQ. Study on the effects of chemistry and pharmacology in Polygonum cuspidatum [in Chinese]. Journal of Chinese Crude Drug 1993; 16: 42.
  • 11
    Ding XC, Run BY, Wang Y. The treatment of neonate jaundice in 88 cases with the combination of traditional Chinese medicine and Western medicine [in Chinese]. National Medicine Forum 2001; 16: 44.
  • 12
    Huang ZS, Wang ZW, Liu MP. The protective effect of resveratrol on rat hepatocytes injured by CCL4 in vitro [in Chinese]. Journal of Pharmacology China 1998; 14: 543.
  • 13
    Zhou X, Lu QJ, Wang L, Ye QN, Wen LQ, Zhang M. Inhibitory effect of resveratrol and its derivatives on HBV in vitro [in Chinese]. China Pharmacology Journal 2005; 40: 19041906.
  • 14
    Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007; 12: 48394854.
  • 15
    Gedik E, Girgin S, Obay BD, Ozturk H, Buyukbayram H. Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J Gastroenterol 2008; 46: 71017106.
  • 16
    Dang SS, Zhang ZG, Zhang X, Song P, Bian J, Cheng YN. Inhibition of hepatitis B virus by emodin and astragalus polysaccharides in vitro [in Chinese]. Journal of Xian Jiaotong University (Medical Sciences) 2007; 28: 521525.
  • 17
    Li Z, Li LJ, Sun Y, Li J. Identification of natural compounds with anti-hepatitis B virus activity from Rheum palmatum L. ethanol extract [in Chinese]. Chemotherapy 2007; 53: 320326.
  • 18
    Liu N, Zhu BX, Huang ZC, Zhu YT, Chen QY, Guo XB, et al. The inhibitive effects of the ethanol extract from Radix et Rhizoma Rhei on the secretion of HBsAg and HBeAg [in Chinese]. Journal of Chinese Crude Drug 2004; 27: 419421.
  • 19
    Ott M, Thyagarajan SP, Gupta S. Phyllanthus amarus suppresses hepatitis B virus by interrupting interaction between HBV enhancer I and cellular transcription factors. Eur J Clin Invest 1997; 27: 908915.
  • 20
    Kang EH, Kown TY, Oh GT, Park WF, Park S-I, Park SK, et al. The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen. Antiviral Res 2006; 72: 100106.
  • 21
    Liu J Lin H, Mcintosh H. Genus Phyllanthus for chronic hepatic B virus infection: a systematic review. J Viral Hepat 2001; 8: 358366.
  • 22
    Strader DB, Bacon R, Lindsay KL, La Brecque DR, Morgan T, Wright EC, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002; 97: 23912397.
    Direct Link: